Anyeep Raises RMB 100 Million in Series A Financing for Mass Spectrometry Development
Anyeep, a Suzhou-based developer of mass spectrometers, has reportedly raised close to RMB 100 million...
Deals
Shanghai Henlius Biotech to Provide R&D Services for COVID-19 Therapy Azvudine
China-based Shanghai Henlius Biotech (HKG: 2696) has entered into an agreement to provide clinical study...
XtalPi Partners with CK Life Sciences to Develop AI Cancer Vaccine Platform
Sino-US artificial intelligence (AI) firm XtalPi Inc. has struck a partnership with China-based CK Life...
Xiling Lab Raises RMB 100 Million for ADC Development and IND Filing
Xiling Lab, a Chengdu-based drug developer specializing in catalytic synthesis technology, has reportedly raised close...
PrimeLink Bio Raises Funds for ADC Development and R&D Expansion
Shenzhen-based drug developer PrimeLink Bio has reportedly raised “hundreds of millions” of renminbi in a...
Visen Pharmaceuticals Files for Hong Kong IPO with Focus on Growth Hormone
Visen Pharmaceuticals, a China-based joint venture between Denmark-headquartered Ascendis Pharma and Chinese healthcare-focused investment firm...
OrbusNeich Files for IPO on Hong Kong Stock Exchange
Vascular intervention specialist OrbusNeich Medical Group Limited, a Wholly Owned Foreign Enterprise (WOFE) based in...
Henlius Biotech Partners with Shantou Central Hospital for Clinical Study Collaboration
China-based Shanghai Henlius Biotech (HKG: 2696) has announced a strategic clinical study cooperation agreement with...
Saint Medical Raises Pre-Series B Funding for Structural Heart Disease Solutions
Saint Medical Technology, a Nanjing-based medical device maker specializing in valvular disease solutions, has reportedly...
JS InnoPharm and Strategia Holdings Form JSI Ventures in Boston
Shanghai-based JS InnoPharm Ltd has announced an agreement with US firm Strategia Holdings LLC to...
Jianke.com Files for Hong Kong IPO with Focus on Chronic Disease Management
China-based smart healthcare service platform Jianke.com (Fangzhou Inc.) has filed for an initial public offering...
Kunshi Biotechnology and Puheng Technology Partner on 3D NAC-Organ Platform for CAR-Macrophage Screening
Kunshi Biotechnology (Shenzhen) Co., Ltd and Suzhou Puheng Technology Co., Ltd have entered into a...
Endoso Life Raises Pre-Series A Funding for High-End Medical Endoscope Development
Endoso Life, a Hangzhou-based developer of high-end medical endoscope systems and devices, has reportedly raised...
Sun-Novo Pharma to Acquire MAH Rights for Azilsartan from Baiao Pharma
China-based Beijing Sun-Novo Pharmaceutical Research Co., Ltd (SHA: 688621) has announced plans to acquire the...
UB Biotechnology Secures Series A Funding for Flow Cytometry Platform
China-based in vitro diagnostics (IVD) maker UB Biotechnology (Zhejiang) Co., Ltd has reportedly raised “tens...
IASO Biotherapeutics Partners with Umoja Biopharma to Evaluate iCIL Platform
China-based biopharma IASO Biotherapeutics has announced a research agreement with US immuno-oncology company Umoja Biopharma,...
Nona Biosciences Licenses HCAb Technology to Dragonfly Therapeutics
Nona Biosciences, a newly established wholly owned subsidiary of Harbour BioMed (HKG: 2142), has struck...
JD Healthcare Partners with Jiangsu Yuyue for Medical Device Collaboration
JD Healthcare, a unit of China’s e-commerce giant JD.com (NASDAQ: JD), has announced a partnership...
ViVest Medical Raises Funds for Wearable Cardioverter Defibrillator Development
Suzhou-based device maker ViVest Medical Technology Co., Ltd has reportedly raised “hundreds of millions” of...
Wolters Kluwer Partners with China’s NCID to Advance Infectious Disease Diagnosis
Holland-based information and software solutions provider Wolters Kluwer has announced a partnership with China’s National...